• For poor metabolisers (PM), a 20 mg daily dose in trimester 1 followed by 30 mg daily in trimesters 2 and 3 is suggested to be optimal. For UM, a 40 mg daily dose throughout gestation is suggested to be optimal. © 2020 Royal Pharmaceutical Society.The aim is to investigate the correlation between computed tomography (CT) features and insulin…[Read more]

  • Background There has been a trend for increased prescribing of levothyroxine (LT4) in many countries, including the United States. Several different factors have been suggested to be the cause of this practice pattern. These factors include increased size of the United States population, more diagnosis of hypothyroidism, more treatment of…[Read more]

  • Hernandez Stryhn became a registered member 6 months, 3 weeks ago